化工社化工社 化学情報印刷レポート · 研究参考用
Methyl Isocyanate → Temozolomide
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Methyl Isocyanate | HCID 12228 | — |
| 反応物 | 4-amino-1H-imidazole-2-carboxamide | HCID 21983288 | — |
| 反応物 | 5-diazo-1H-imidazole-4-carboxamide | HCID 136377446 | — |
| 溶媒 | Dichloromethane | HCID 6344 | — |
| 生成物 | Temozolomide | HCID 5394 | — |
反応手順
In this process, 5-amino-1H-imidazole-carboxamide (A) is converted into 5-diazo-1H-imidazole-4-carboxamide (B), which is then cyclized with methylisocyanate in dichloromethane to provide a high yield of clinical-grade Temozolomide. However, this process requires isolation of the unstable and potentially dangerous 5-diazo-1H-imidazole-4-carboxamide (B). Moreover, methylisocyanate is a difficult reagent to handle and ship, especially on the industrial scale, and indeed is better avoided in industrial manufacture. Furthermore, the cycloaddition of methylisocyanate requires a very long reaction time: Table I in J. Med. Chem. 1984, 27, 196-201, suggests 20 days.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US07737284B2 |
| 出典データセット | uspto-grants-2010_06 |
| ORD ID | ord-d39ed1e4e8d04f3592ef23528a553348 |
| 出典メモ | uspto-grants-2010_06 |